Pfizer Alzheimer’s disease drug fails in study (AP via Yahoo! News)

A promising Alzheimer’s disease drug Pfizer Inc. and a partner are developing failed to work in a late-stage study, a startling disappointment after the potential blockbuster kept symptoms from worsening for a year in a prior test.

Originally posted here:
Pfizer Alzheimer’s disease drug fails in study (AP via Yahoo! News)

Tags: from-worsening, alzheimer, a-partner-are, a-startling-disappointme, late-stage-study, after-the

Related posts:

  1. Pfizer Alzheimer’s drug fails in study (USA Today)
  2. Drug fails in one BU Alzheimer study, hormone link seen in other
  3. Alzheimer’s drug Dimebon helps Huntington’s: study (Reuters via Yahoo! News)
  4. Alzheimer’s drug trial altered after 9 deaths (AP via Yahoo! News)
  5. Sea Squirt Helps Researchers Test New Alzheimer’s Drug (HealthDay via Yahoo! News)

This entry was posted on Wednesday, March 3rd, 2010 at 8:53 pm and is filed under Alzheimer's Disease. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply